In sum, these findings emphasize an increased fraction of mature CD38+ NK-cells, either FAS- or TIM3-expressing, in vaccine-responders among patients with MM, which show a cytokine responsive phenotype, particularly after in vitro TNF-α stimulation. The gene discussed is TNF; the disease is Miyoshi myopathy.